Mesoblast (MESO) Times Interest Earned (2014 - 2023)
Mesoblast (MESO) posted quarterly Times Interest Earned of $0.39 for Q2 2023, up 8420.37% year-on-year from $0.0 in Q2 2022, and up 303.5% on a QoQ basis from -$0.19 in Q1 2023.
Mesoblast (MESO) Times Interest Earned (2014 - 2023) Analysis & Trends
Mesoblast (MESO) has reported Times Interest Earned for 10 consecutive years, with $0.39 the latest figure, recorded in Q2 2023.
- Quarterly Times Interest Earned rose 8420.37% year-over-year to $0.39 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was -$0.27 (up 91.02% YoY) and the FY2025 annual result came in at -$2.7, down 5.72% from the prior year.
- Times Interest Earned grew to $0.39 in Q2 2023 per MESO's latest filing, from -$0.19 in the prior quarter.
- Over the last five years, Times Interest Earned for MESO reached as high as $20.12 in Q2 2021 and fell as low as -$7.64 in Q1 2019.
- A 5-year average of -$0.6 and a median of -$1.19 in 2019 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2020 — Times Interest Earned plunged 406.65% — and 2023, when it jumped 8420.37%.
- Year by year, Times Interest Earned stood at -$6.46 in 2019, then gained by 16.13% to -$5.41 in 2020, then surged by 207.82% to $5.84 in 2021, then slumped by 122.24% to -$1.3 in 2022, then soared by 129.77% to $0.39 in 2023.
- According to Business Quant data, Times Interest Earned over the past three periods registered $0.39, -$0.19, and -$1.3 for Q2 2023, Q1 2023, and Q4 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 0.39 |
| Mar 31, 2023 | -0.19 |
| Dec 31, 2022 | -1.30 |
| Sep 30, 2022 | -2.72 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | -0.65 |
| Dec 31, 2021 | 5.84 |
| Sep 30, 2021 | -4.48 |
| Jun 30, 2021 | 20.12 |
| Mar 31, 2021 | -5.74 |
| Dec 31, 2020 | -5.41 |
| Sep 30, 2020 | -5.44 |
| Jun 30, 2020 | -0.46 |
| Mar 31, 2020 | -3.61 |
| Dec 31, 2019 | -6.46 |
| Sep 30, 2019 | -1.07 |
| Jun 30, 2019 | 7.99 |
| Mar 31, 2019 | -7.64 |
| Dec 31, 2018 | 12.05 |
| Sep 30, 2018 | 8.62 |